Abstract:MicroRNAs (miRs) may induce mRNA degradation or inhibit protein translation by directly binding to the 3'-untranslational region of target mRNAs. It has been reported that miR-138 is downregulated in malignant melanoma (MM) cells. However, the role of miR-138 in MM cell proliferation, invasion and energy metabolism remains unknown. These were investigated using reverse transcription-quantitative polymerase chain reaction was used to evaluate the expression of miR-138 and the mRNA expression of hypoxia-inducible factor-1α (HIF-1α), as HIF-1α serves a crucial role in glycolysis, which is important for tumor growth. In addition, western blot analysis was used to detected the protein expression of HIF-1α, while MTT and Transwell assays evaluated cell proliferation and invasion, respectively. Furthermore, glucose consumption and lactic acid production were assessed. These tests were conducted using the normal human melanocyte cell line HM and the MM cell line WM451, which was transfected variously with scramble miR mimics, miR-138 mimics, miR-138 inhibitor, non-specific small interfering (si)RNA, HIF-1α siRNA, or co-transfected with miR-138 mimics and pc-DNA3.1(+)-HIF-1α plasmid. The results showed that miR-138 was significantly downregulated in MM WM451 cells compared to a normal melanocyte cell line HM. Overexpression of miR-138 significantly inhibited the proliferation and invasion of WM451 cells. These effects were similar to those induced by the siRNA-mediated knockdown of HIF-1α, a direct target of miR-138. Further investigation found that miR-138 negatively regulated the protein expression of HIF-1α in WM451 cells. Moreover, upregulation of miR-138 notably inhibited the glycolysis level, as demonstrated by reduced glucose consumption and lactic acid production, which could be reversed by the overexpression of HIF-1α. In summary, the present study demonstrated that miR-138 is able to inhibit proliferation, invasion and glycolysis in MM cells, potentially by directly targeting HIF-1α.

miR-137 inhibits melanoma cell proliferation through downregulation of GLO1

miR‐137 inhibits proliferation of melanoma cells by targeting PAK2

MicroRNA-138 suppresses proliferation, invasion and glycolysis in malignant melanoma cells by targeting HIF-1α.

MicroRNA-137 inhibits growth of glioblastoma through EGFR suppression.

Microrna-138 Modulates Glioma Cell Growth, Apoptosis And Invasion Through The Suppression Of The Akt/Mtor Signalling Pathway By Targeting Creb1

Hypoxia-Induced miR-137 Inhibition Increased Glioblastoma Multiforme Growth and Chemoresistance Through LRP6

Mir-138-5p Suppresses Glioblastoma Cell Viability and Leads to Cell Cycle Arrest by Targeting Cyclin D3.

MiR-137 targets and regulates E2F7 to suppress progression of glioma cells

LINC00662 Promotes Melanoma Progression by Competitively Binding Mir-107 and Activating the Β-Catenin Signaling Pathway.

Suppressive effect of miR-137 on proliferation and apoptosis of U87 glioma cells in vitro

MicroRNA-1468-5p Inhibits Glioma Cell Proliferation and Induces Cell Cycle Arrest by Targeting RRM1.

miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2.

MicroRNA-137 Targets Carboxyl-terminal Binding Protein 1 in Melanoma Cell Lines

Microrna-1471 Suppresses Glioma Cell Growth and Invasion by Repressing Metadherin Expression.

MicroRNA-509-3p Inhibits Cell Proliferation and Invasion Via Downregulation of X-linked Inhibitor of Apoptosis in Glioma.

MicroRNA-138 suppresses glioblastoma proliferation through downregulation of CD44

Overexpressed Mirna-137 Inhibits Human Glioma Cells Growth by Targeting Rac1

miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.

Mir-508-5p Inhibits the Progression of Glioma by Targeting Glycoprotein Non-Metastatic Melanoma B

MicroRNA-193a-5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1

Microrna-9 Inhibits the Proliferation and Migration of Malignant Melanoma Cells Via Targeting Sirituin 1